McCarthy Sean A. — SEC insider filings
SEC reporting owner CIK 1654058. 32 insider filings on record with FilingPulse; latest filed 2026-10-16.
Transaction summary — filings shown
Covers all 32 filings on record, filed 2020-09-23 to 2026-10-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 13 legs across 13 filings — 700,027 shares, $3,445,261 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 54.
- Largest priced transaction: sale of 118,969 shares @ $6.42 ($764,138) in CytomX Therapeutics, Inc., filed 2026-03-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CytomX Therapeutics, Inc. (CTMX) | CEO, Director | 32 | — | 13 legs · 700,027 sh · $3,445,261 | 54 |
Insider filings — McCarthy Sean A.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-16 | 4/A | CytomX Therapeutics, Inc. (CTMX) | Option exercise (M): 101,793 @ $1.59 · Sale (S): 101,793 @ $4.54 · Option exercise (M): 101,793 (derivative) @ $0 | EDGAR |
| 2026-03-19 | 4 | CytomX Therapeutics, Inc. (CTMX) | Sale (S): 118,969 @ $6.42 | EDGAR |
| 2026-02-04 | 4 | CytomX Therapeutics, Inc. (CTMX) | Grant/award (A): 210,000 @ $0 · Grant/award (A): 980,000 (derivative) @ $0 | EDGAR |
| 2025-11-10 | 4 | CytomX Therapeutics, Inc. (CTMX) | Sale (S): 101,793 @ $4.54 | EDGAR |
| 2025-09-30 | 4 | CytomX Therapeutics, Inc. (CTMX) | Grant/award (A): 570,000 (derivative) @ $0 · Grant/award (A): 285,000 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | CytomX Therapeutics, Inc. (CTMX) | Option exercise (M): 150,000 @ $0 · Sale (S): 55,511 @ $2.69 · Option exercise (M): 150,000 (derivative) @ $0 | EDGAR |
| 2025-03-20 | 4 | CytomX Therapeutics, Inc. (CTMX) | Sale (S): 37,656 @ $0.60 | EDGAR |
| 2025-02-06 | 4 | CytomX Therapeutics, Inc. (CTMX) | Grant/award (A): 180,000 @ $0 · Grant/award (A): 195,000 @ $0 · Grant/award (A): 800,000 (derivative) @ $0 · Grant/award (A): 390,000 (derivative) @ $0 | EDGAR |
| 2024-08-22 | 4 | CytomX Therapeutics, Inc. (CTMX) | Option exercise (M): 37,500 @ $0 · Sale (S): 13,898 @ $1.23 · Option exercise (M): 37,500 (derivative) @ $0 | EDGAR |
| 2024-03-28 | 4 | CytomX Therapeutics, Inc. (CTMX) | Option exercise (M): 109,768 @ $1.57 · Option exercise (M): 109,768 (derivative) @ $0 | EDGAR |
| 2024-03-21 | 4 | CytomX Therapeutics, Inc. (CTMX) | Sale (S): 20,223 @ $2.09 | EDGAR |
| 2024-01-19 | 4 | CytomX Therapeutics, Inc. (CTMX) | Grant/award (A): 90,000 @ $0 · Grant/award (A): 420,000 (derivative) @ $0 · Grant/award (A): 260,000 (derivative) @ $0 | EDGAR |
| 2023-12-22 | 4 | CytomX Therapeutics, Inc. (CTMX) | Sale (S): 13,551 @ $1.38 | EDGAR |
| 2023-12-19 | 4 | CytomX Therapeutics, Inc. (CTMX) | Option exercise (M): 37,500 @ $0 · Option exercise (M): 37,500 (derivative) @ $0 | EDGAR |
| 2023-09-22 | 4 | CytomX Therapeutics, Inc. (CTMX) | Grant/award (A): 40,000 @ $0 · Sale (S): 14,601 @ $1.30 | EDGAR |
| 2023-05-23 | 4 | CytomX Therapeutics, Inc. (CTMX) | Option exercise (M): 16,535 @ $1.57 · Option exercise (M): 16,535 (derivative) @ $0 | EDGAR |
| 2023-03-20 | 4 | CytomX Therapeutics, Inc. (CTMX) | Sale (S): 7,121 @ $1.88 | EDGAR |
| 2023-02-06 | 4 | CytomX Therapeutics, Inc. (CTMX) | Grant/award (A): 105,000 @ $0 · Grant/award (A): 315,000 (derivative) @ $0 · Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2022-08-12 | 4 | CytomX Therapeutics, Inc. (CTMX) | Grant/award (A): 450,000 (derivative) @ $0 · Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2022-07-21 | 4 | CytomX Therapeutics, Inc. (CTMX) | Grant/award (A): 40,000 @ $0 · Sale (S): 14,911 @ $1.42 | EDGAR |
| 2022-05-11 | 4 | CytomX Therapeutics, Inc. (CTMX) | Option exercise (M): 66,742 @ $0.94 · Option exercise (M): 24,189 @ $0.94 · Option exercise (M): 66,742 (derivative) @ $0 · Option exercise (M): 24,189 (derivative) @ $0 | EDGAR |
| 2022-02-04 | 4 | CytomX Therapeutics, Inc. (CTMX) | Grant/award (A): 75,000 @ $0 · Grant/award (A): 450,000 (derivative) @ $0 | EDGAR |
| 2021-10-26 | 4 | CytomX Therapeutics, Inc. (CTMX) | Grant/award (A): 100,000 (derivative) @ $0 · Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2021-08-13 | 4 | CytomX Therapeutics, Inc. (CTMX) | Option exercise (M): 92,113 @ $1.13 · Option exercise (M): 92,113 (derivative) @ $0 | EDGAR |
| 2021-06-21 | 4 | CytomX Therapeutics, Inc. (CTMX) | Sale (S): 100,000 @ $7.04 | EDGAR |
| 2021-06-16 | 4 | CytomX Therapeutics, Inc. (CTMX) | Option exercise (M): 30 @ $1.13 · Option exercise (M): 10 @ $0.94 · Option exercise (M): 30 (derivative) @ $0 · Option exercise (M): 10 (derivative) @ $0 | EDGAR |
| 2021-06-08 | 4 | CytomX Therapeutics, Inc. (CTMX) | Gift (G): 4,500 @ $0 | EDGAR |
| 2021-04-02 | 4 | CytomX Therapeutics, Inc. (CTMX) | Option exercise (M): 100,000 @ $1.13 · Sale (S): 100,000 @ $7.49 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2021-03-02 | 4 | CytomX Therapeutics, Inc. (CTMX) | Grant/award (A): 400,000 (derivative) @ $0 · Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2020-12-28 | 4 | CytomX Therapeutics, Inc. (CTMX) | Option exercise (M): 100,000 @ $1.13 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2020-12-07 | 4 | CytomX Therapeutics, Inc. (CTMX) | Grant/award (A): 930 @ $6.39 | EDGAR |
| 2020-09-23 | 4 | CytomX Therapeutics, Inc. (CTMX) | Option exercise (M): 20,500 @ $6.61 · Option exercise (M): 20,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-21 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1654058 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs